{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:27:31Z","timestamp":1778056051255,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.clon.2009.05.004","type":"journal-article","created":{"date-parts":[[2009,7,4]],"date-time":"2009-07-04T04:30:58Z","timestamp":1246681858000},"page":"543-556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Chemoradiotherapy in Gastrointestinal Malignancies"],"prefix":"10.1016","volume":"21","author":[{"given":"C.G.","family":"Willett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.G.","family":"Czito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2009.05.004_bib1","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/1097-0142(197906)43:6<2254::AID-CNCR2820430616>3.0.CO;2-A","article-title":"Carcinoma of the esophagus: pretreatment assessment, correlation of radiation treatment parameters with survival, and identification and management of radiation treatment failure","volume":"43","author":"Beatty","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2009.05.004_bib2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib3","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJM199608153350702","article-title":"A comparison of multimodal therapy and surgery for esophageal adenocarcinoma","volume":"335","author":"Walsh","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.2001.19.2.305","article-title":"Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma","volume":"19","author":"Urba","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199707173370304","article-title":"Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus","volume":"337","author":"Bosset","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(05)70288-6","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial","volume":"6","author":"Burmeister","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib7","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781","volume":"26","author":"Tepper","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/gut.2003.025080","article-title":"Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis","volume":"53","author":"Fiorica","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.clon.2009.05.004_bib9","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9610(03)00066-7","article-title":"A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer","volume":"185","author":"Urschel","year":"2003","journal-title":"Am J Surg"},{"key":"10.1016\/j.clon.2009.05.004_bib10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1470-2045(07)70039-6","article-title":"Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis","volume":"8","author":"Gebski","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1200\/JCO.2008.17.0506","article-title":"Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction","volume":"27","author":"Stahl","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1200\/JCO.1997.15.1.277","article-title":"Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study","volume":"15","author":"al-Sarraf","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib13","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/1097-0142(19910501)67:9<2258::AID-CNCR2820670908>3.0.CO;2-G","article-title":"A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus","volume":"67","author":"Araujo","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2009.05.004_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-642-83293-2_3","article-title":"Controlled clinical trial for the treatment of patients with inoperable esophageal carcinoma: a study of EORTC Gastrointestinal Tract Cancer Cooperative Group","volume":"110","author":"Roussell","year":"1988","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.clon.2009.05.004_bib15","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","article-title":"Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus","volume":"326","author":"Herskovic","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib16","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(02)08651-8","article-title":"Group MRCOCW. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2009.05.004_bib17","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2007.25.18_suppl.4510","article-title":"Final results of a randomized trial comparing preoperative 5-fluorouracil (F)\/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (SLE): FNLCC ACCORDO7-FFCD 9703 trial","volume":"25","author":"Boige","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib19","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJM199812313392704","article-title":"Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer","volume":"339","author":"Kelsen","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib21","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2005.00.034","article-title":"Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus","volume":"23","author":"Stahl","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib22","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","article-title":"Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102","volume":"25","author":"Bedenne","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib23","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1200\/JCO.2005.00.448","article-title":"Outcome results of the 1996\u20131999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagus","volume":"23","author":"Suntharalingam","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib24","first-page":"784","volume":"28","author":"Sun","year":"2006","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"18S","key":"10.1016\/j.clon.2009.05.004_bib25","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1200\/jco.2007.25.18_suppl.4530","article-title":"A randomized trial of chemoradiotherapy versus surgery alone in patients with resectable esophageal cancer","volume":"25","author":"Carstens","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0002-9610(05)80406-4","article-title":"Prognostic indicators for survival after resection of pancreatic adenocarcinoma","volume":"165","author":"Geer","year":"1993","journal-title":"Am J Surg"},{"key":"10.1016\/j.clon.2009.05.004_bib27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000658-200301000-00011","article-title":"Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients","volume":"237","author":"Lim","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.clon.2009.05.004_bib28","series-title":"Cancer of the pancreas","author":"Evans","year":"2001"},{"key":"10.1016\/j.clon.2009.05.004_bib29","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/1097-0142(197603)37:3<1519::AID-CNCR2820370340>3.0.CO;2-O","article-title":"Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy","volume":"37","author":"Tepper","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2009.05.004_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6","article-title":"Patterns of failure after curative resection of pancreatic carcinoma","volume":"66","author":"Griffin","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2009.05.004_bib31","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0360-3016(91)90268-9","article-title":"Adjuvant therapy of resected adenocarcinoma of the pancreas","volume":"21","author":"Whittington","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.004_bib32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF02927065","article-title":"Improvement of pancreatic cancer treatment from the Japanese experience in the 1980s","volume":"12","author":"Ozaki","year":"1992","journal-title":"Int J Pancreatol"},{"key":"10.1016\/j.clon.2009.05.004_bib33","first-page":"384","article-title":"Recurrence of exocrine pancreatic cancer\u2014local or hepatic?","volume":"40","author":"Westerdahl","year":"1993","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.clon.2009.05.004_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00000658-199302000-00008","article-title":"Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy","volume":"217","author":"Willett","year":"1993","journal-title":"Ann Surg"},{"key":"10.1016\/j.clon.2009.05.004_bib35","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/1097-0142(19950415)75:8<2069::AID-CNCR2820750807>3.0.CO;2-7","article-title":"Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region","volume":"75","author":"Allema","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2009.05.004_bib36","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archsurg.1985.01390320023003","article-title":"Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection","volume":"120","author":"Kalser","year":"1985","journal-title":"Arch Surg"},{"key":"10.1016\/j.clon.2009.05.004_bib37","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19870615)59:12<2006::AID-CNCR2820591206>3.0.CO;2-B","article-title":"Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer","volume":"59","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2009.05.004_bib38","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","article-title":"Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group","volume":"230","author":"Klinkenbijl","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.clon.2009.05.004_bib39","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(01)06651-X","article-title":"Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial","volume":"358","author":"Neoptolemos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2009.05.004_bib40","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib41","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2008.26.15_suppl.lba4504","article-title":"CONKO-001: final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC)","volume":"26","author":"Neuhaus","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib42","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jama.299.9.1019","article-title":"Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial","volume":"299","author":"Regine","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.clon.2009.05.004_bib43","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clon.2009.05.004_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/1097-0142(19860701)58:1<22::AID-CNCR2820580106>3.0.CO;2-Q","article-title":"Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study","volume":"58","author":"Balslev","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2009.05.004_bib45","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1056\/NEJM198611133152014","article-title":"Survival after postoperative combination treatment of rectal cancer","volume":"315","author":"Douglass","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib46","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJM198506063122301","article-title":"Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma","volume":"312","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib47","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jama.1990.03450110090034","article-title":"Adjuvant therapy for patients with colon and rectal cancer","volume":"264","author":"NIH Consensus Conference","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.clon.2009.05.004_bib48","first-page":"1291","article-title":"Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2009.05.004_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jnci\/80.1.21","article-title":"Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01","volume":"80","author":"Fisher","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clon.2009.05.004_bib50","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199103143241101","article-title":"Effective surgical adjuvant therapy for high-risk rectal carcinoma","volume":"324","author":"Krook","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib51","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM199408253310803","article-title":"Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery","volume":"331","author":"O'Connell","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib52","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1200\/JCO.2005.04.9544","article-title":"Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144","volume":"24","author":"Smalley","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib53","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1200\/JCO.1997.15.5.2030","article-title":"Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114","volume":"15","author":"Tepper","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib54","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jnci\/92.5.388","article-title":"Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02","volume":"92","author":"Wolmark","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl.","key":"10.1016\/j.clon.2009.05.004_bib55","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1002\/bjs.1800721333","article-title":"Adjuvant radiotherapy in rectal cancer: the MRC trials","volume":"72","author":"Duncan","year":"1985","journal-title":"Br J Surg"},{"key":"10.1016\/j.clon.2009.05.004_bib56","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203","volume":"24","author":"Gerard","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib57","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/1097-0142(19860715)58:2<352::AID-CNCR2820580226>3.0.CO;2-D","article-title":"Preoperative radiation and surgery for cancer of the rectum. Veterans Administration Surgical Oncology Group Trial II","volume":"58","author":"Higgins","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2009.05.004_bib58","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2214\/ajr.114.3.498","article-title":"Preoperative irradiation of rectosigmoid carcinoma including its regional lymph nodes","volume":"114","author":"Kligerman","year":"1972","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"10.1016\/j.clon.2009.05.004_bib59","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJM199704033361402","article-title":"Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib60","doi-asserted-by":"crossref","first-page":"8697","DOI":"10.1200\/JCO.2005.02.9017","article-title":"Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial","volume":"23","author":"Birgisson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib61","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1200\/JCO.1999.17.8.2396","article-title":"Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial","volume":"17","author":"Francois","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib62","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/bjs.1800691019","article-title":"The mesorectum in rectal cancer surgery\u2014the clue to pelvic recurrence?","volume":"69","author":"Heald","year":"1982","journal-title":"Br J Surg"},{"key":"10.1016\/j.clon.2009.05.004_bib63","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib64","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jama.284.8.1008","article-title":"Preoperative radiotherapy for resectable rectal cancer: a meta-analysis","volume":"284","author":"Camma","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clon.2009.05.004_bib65","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1200\/JCO.2005.02.113","article-title":"Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results \u2014 EORTC 22921","volume":"23","author":"Bosset","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib66","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib67","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2006.24.18_suppl.3527","article-title":"Sphincter preserving surgery after preoperative treatment for ultra-low rectal carcinoma. A French multicenter prospective trial: CRECCAR 1","volume":"24","author":"Rouanet","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2003.12.006","article-title":"Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy","volume":"72","author":"Bujko","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib69","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","article-title":"Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer","volume":"93","author":"Bujko","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.clon.2009.05.004_bib70","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF02054976","article-title":"A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03","volume":"40","author":"Hyams","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clon.2009.05.004_bib71","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2009.05.004_bib72","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2006.24.18_suppl.3511","article-title":"Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomized trial","volume":"24","author":"Sebag-Montefiore","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib73","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2009.05.004_bib74","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1040-8428(00)00059-7","article-title":"Capecitabine, a new oral fluoropyrimidine for the treatment of colorectal cancer","volume":"35","author":"Di Costanzo","year":"2000","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clon.2009.05.004_bib75","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/annonc\/mdi212","article-title":"A phase I\u2013II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer","volume":"16","author":"Aschele","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib76","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/annonc\/mdi406","article-title":"Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study","volume":"16","author":"Machiels","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib77","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1200\/JCO.2003.02.505","article-title":"Phase I\/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer","volume":"21","author":"Rodel","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib78","first-page":"273","article-title":"ECOG 1297: a phase I study of preoperative radiation therapy (RT) with concurrent protracted continuous infusion 5-FU and dose escalating oxaliplatin followed by surgery, adjuvant 5-FU, and leucovorin for locally advanced (T3\/4) rectal adenocarcinoma","volume":"22","author":"Rosenthal","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib79","first-page":"262","article-title":"Chemoradiation with CPT-11, 5FU in neoadjuvant treatment of locally advanced or recurrent adenocarcinoma of the rectum: a phase I\/II study update","volume":"22","author":"Mitchell","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.004_bib80","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nm988","article-title":"Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer","volume":"10","author":"Willett","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.clon.2009.05.004_bib81","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijrobp.2007.02.001","article-title":"Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: phase I trial results","volume":"68","author":"Czito","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.004_bib82","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/bjs.6470","article-title":"Non-operative management of rectal cancer after neoadjuvant chemoradiation","volume":"96","author":"Habr-Gama","year":"2009","journal-title":"Br J Surg"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655509001526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655509001526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:34:47Z","timestamp":1760542487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655509001526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0936655509001526"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2009.05.004","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemoradiotherapy in Gastrointestinal Malignancies","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2009.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}